Tahamtan Ahmadi

Person

Spring House, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific antibodies against CD3 and CD20 for treating chronic lym...
- Patent number 11,858,995
- Issue date Jan 2, 2024
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody against CD3 and CD20 in combination therapy for...
- Patent number 11,845,805
- Issue date Dec 19, 2023
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating high risk multiple myeloma
- Patent number 11,618,787
- Issue date Apr 4, 2023
- Janssen Biotech, Inc.
- Tahamtan Ahmadi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody against CD3 and CD20 in combination therapy for...
- Patent number 11,608,383
- Issue date Mar 21, 2023
- GENMAB A/S
- Brian Elliott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibody against CD3 and CD20 in combination therapy for...
- Patent number 11,548,952
- Issue date Jan 10, 2023
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody against CD3 and CD20 in combination therapy for...
- Patent number 11,535,679
- Issue date Dec 27, 2022
- GENMAB A/S
- Brian Elliott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immune modulation and treatment of solid tumors with antibodies tha...
- Patent number 11,021,543
- Issue date Jun 1, 2021
- Janssen Biotech, Inc.
- Tahamtan Ahmadi
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Immune Modulation and Treatment of Solid Tumors with Antibodies tha...
- Publication number 20250066501
- Publication date Feb 27, 2025
- JANSSEN BIOTECH, INC.
- Tahamtan Ahmadi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20240301078
- Publication date Sep 12, 2024
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TROGOCYTOSIS-MEDIATED THERAPY USING CD38 ANTIBODIES
- Publication number 20240254252
- Publication date Aug 1, 2024
- GENMAB A/S
- Bart E. C. G. DE GOEIJ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY AND TAXANE COMBINATION THERAPY
- Publication number 20240109972
- Publication date Apr 4, 2024
- GENMAB A/S
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20240034812
- Publication date Feb 1, 2024
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20230355753
- Publication date Nov 9, 2023
- GENMAB A/S
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20230357440
- Publication date Nov 9, 2023
- GENMAB A/S
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating High Risk Multiple Myeloma
- Publication number 20230340145
- Publication date Oct 26, 2023
- JANSSEN BIOTECH, INC.
- Tahamtan Ahmadi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20230312758
- Publication date Oct 5, 2023
- Brian ELLIOTT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYM...
- Publication number 20230312757
- Publication date Oct 5, 2023
- GENMAB A/S
- Brian ELLIOTT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20230312759
- Publication date Oct 5, 2023
- GENMAB A/S
- Brian ELLIOTT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
- Publication number 20230227570
- Publication date Jul 20, 2023
- GENMAB A/S
- Tahamtan AHMADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE REGIMENS FOR A COMBINATION OF ANTI-DR5 ANTIBODIES FOR USE IN...
- Publication number 20220315661
- Publication date Oct 6, 2022
- GENMAB B.V.
- Ulf FORSSMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER
- Publication number 20220273809
- Publication date Sep 1, 2022
- GENMAB A/S
- Maarten JANMAAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220144964
- Publication date May 12, 2022
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220119544
- Publication date Apr 21, 2022
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220112300
- Publication date Apr 14, 2022
- GENMAB A/S
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYM...
- Publication number 20220112287
- Publication date Apr 14, 2022
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220112301
- Publication date Apr 14, 2022
- GENMAB A/S
- Brian Elliott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...
- Publication number 20220112309
- Publication date Apr 14, 2022
- GENMAB A/S
- Brian ELLIOTT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immune Modulation and Treatment of Solid Tumors with Antibodies tha...
- Publication number 20210403592
- Publication date Dec 30, 2021
- Tahamtan Ahmadi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AXL-SPECIFIC ANTIBODIES FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
- Publication number 20210393793
- Publication date Dec 23, 2021
- GENMAB A/S
- Esther BREIJ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
- Publication number 20210371538
- Publication date Dec 2, 2021
- GENMAB A/S
- Tahamtan AHMADI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT
- Publication number 20210070869
- Publication date Mar 11, 2021
- GENMAB A/S
- Maarten JANMAAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VARIANTS OF CD38 ANTIBODY AND USES THEREOF
- Publication number 20200165352
- Publication date May 28, 2020
- GENMAB A/S
- Bart De GOEIJ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VARIANTS OF CD38 ANTIBODY AND USES THEREOF
- Publication number 20200017600
- Publication date Jan 16, 2020
- GENMAB A/S
- Bart De GOEIJ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immune Modulation and Treatment of Solid Tumors with Antibodies tha...
- Publication number 20190144557
- Publication date May 16, 2019
- Tahamtan Ahmadi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of Treating High Risk Multiple Myeloma
- Publication number 20190127479
- Publication date May 2, 2019
- Tahamtan Ahmadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immune Modulation and Treatment of Solid Tumors with Antibodies tha...
- Publication number 20170044265
- Publication date Feb 16, 2017
- JANSSEN BIOTECH, INC.
- Tahamtan Ahmadi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Immune Modulation and Treatment of Solid Tumors with Antibodies tha...
- Publication number 20160376373
- Publication date Dec 29, 2016
- JANSSEN BIOTECH, INC.
- Tahamtan Ahmadi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Tahamtan Ahmadi

Person

Patents Grantslast 30 patents

Bispecific antibodies against CD3 and CD20 for treating chronic lym...

Bispecific antibody against CD3 and CD20 in combination therapy for...

Methods of treating high risk multiple myeloma

Bispecific antibody against CD3 and CD20 in combination therapy for...

Bispecific antibody against CD3 and CD20 in combination therapy for...

Bispecific antibody against CD3 and CD20 in combination therapy for...

Immune modulation and treatment of solid tumors with antibodies tha...

Patents Applicationslast 30 patents

Immune Modulation and Treatment of Solid Tumors with Antibodies tha...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

TROGOCYTOSIS-MEDIATED THERAPY USING CD38 ANTIBODIES

ANTIBODY AND TAXANE COMBINATION THERAPY

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

Methods of Treating High Risk Multiple Myeloma

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYM...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20

DOSAGE REGIMENS FOR A COMBINATION OF ANTI-DR5 ANTIBODIES FOR USE IN...

AXL ANTIBODY-DRUG CONJUGATES FOR USE IN TREATING CANCER

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING CHRONIC LYM...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR...

Immune Modulation and Treatment of Solid Tumors with Antibodies tha...

AXL-SPECIFIC ANTIBODIES FOR TREATMENT OF NON-SMALL CELL LUNG CANCER

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20

AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT

VARIANTS OF CD38 ANTIBODY AND USES THEREOF

VARIANTS OF CD38 ANTIBODY AND USES THEREOF

Immune Modulation and Treatment of Solid Tumors with Antibodies tha...

Methods of Treating High Risk Multiple Myeloma

Immune Modulation and Treatment of Solid Tumors with Antibodies tha...

Immune Modulation and Treatment of Solid Tumors with Antibodies tha...